Given the close links between insulin resistance, endothelial dysfunction, and cardiovascular disease, addressing the dual impact of iatrogenic peripheral hyperinsulinemia on insulin sensitivity [16] and endothelial health [17] becomes an important target for reducing the burden of cardiovascular disease in type 1 diabetes. This evidence concerns the gene INS and endothelial dysfunction.